InfectoPharm Arzneimittel und Consilium GmbH

InfectoPharm Arzneimittel und Consilium GmbH is a family-run company specializing in the new and further development of medicines for children. This has given us a strong position in Germany. Every single one of our products offers patients, doctors and pharmacists exactly the special added value that they have come to know and expect from us after more than 30 years. The consilium bundles medical services and sees itself as an advertising-free place for knowledge transfer and interdisciplinary exchange for specialist groups.

With over 130 preparations, around 400 employees and international partnerships in 30 countries, InfectoPharm has achieved above-average sales growth, particularly in the last 14 years. This has not gone unnoticed: in 2017, the London Stock Exchange Group (LSEG) included us as one of 1000 Companies to Inspire Europe in its annual analyst report on outstanding European SMEs.

Our medicines contain scientifically researched and medically proven active ingredients that we adapt and further develop to meet the needs of children. They differ significantly from existing preparations in terms of galenics, potency, dosage form and taste. One of InfectoPharm's typical medicines is a juice. With the GeriaSan® brand, InfectoPharm also offers liquid medicines for older people with swallowing disorders (dysphagia). Special active ingredients against resistant bacteria in hospitals are another of our important impulses towards patient-centered therapy.

Many preparations are also available in pharmacies without a prescription. Pädia GmbH, which we integrated in 2015, specializes in products for self-medication that are particularly easy to use in children.

The InfectoPharm Group includes the two German subsidiaries Pädia GmbH and Beyvers GmbH as well as branches in Austria, Italy, France and the UK, which distribute part of InfectoPharm's portfolio.